What If Alzheimer's Plaques Aren't the Root Problem? 🧠

Researchers have spent years developing treatments that target plaque buildup in the brain. But what if that buildup is a consequence of Alzheimer's rather than its underlying cause? Dr. Trevor Martin, co-founder and CEO of Mammoth Biosciences, explains why genetic medicines offer a different approach. When scientists can identify the genetic cause of a disease, gene editing could target it directly rather than addressing downstream effects. Alzheimer's is more complex, but AI could help researchers identify the genetic targets worth investigating. Watch the full episode! #AlzheimersResear